0001683168-23-002856.txt : 20230502 0001683168-23-002856.hdr.sgml : 20230502 20230502194405 ACCESSION NUMBER: 0001683168-23-002856 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230501 FILED AS OF DATE: 20230502 DATE AS OF CHANGE: 20230502 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ziebell Mark R CENTRAL INDEX KEY: 0001552642 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32839 FILM NUMBER: 23881197 MAIL ADDRESS: STREET 1: 14282 FRANKLIN AVENUE CITY: TUSTIN STATE: CA ZIP: 92780 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Avid Bioservices, Inc. CENTRAL INDEX KEY: 0000704562 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 953698422 STATE OF INCORPORATION: DE FISCAL YEAR END: 0430 BUSINESS ADDRESS: STREET 1: 14191 MYFORD ROAD CITY: TUSTIN STATE: CA ZIP: 92780 BUSINESS PHONE: 714.508.6100 MAIL ADDRESS: STREET 1: 14191 MYFORD ROAD CITY: TUSTIN STATE: CA ZIP: 92780 FORMER COMPANY: FORMER CONFORMED NAME: PEREGRINE PHARMACEUTICALS INC DATE OF NAME CHANGE: 20001109 FORMER COMPANY: FORMER CONFORMED NAME: TECHNICLONE CORP/DE/ DATE OF NAME CHANGE: 19970924 FORMER COMPANY: FORMER CONFORMED NAME: TECHNICLONE INTERNATIONAL CORP DATE OF NAME CHANGE: 19920703 4 1 ownership.xml X0407 4 2023-05-01 0 0000704562 Avid Bioservices, Inc. CDMO 0001552642 Ziebell Mark R 14191 MYFORD ROAD TUSTIN CA 92780 0 1 0 0 V. P., General Counsel 1 Common Stock, $0.001 par value 2023-05-01 4 M 0 25000 9.87 A 65119 D Common Stock, $0.001 par value 2023-05-01 4 S 0 25000 17.9141 D 40119 D Stock Option (right to buy) 9.87 2023-05-01 4 M 0 25000 0.0000 D 2023-05-06 Common Stock 25000 214145 D The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 17, 2022. Represents a weighted average sales price per share. These shares were sold at prices ranging from $17.54 to $18.25. The Reporting Person has provided to the Issuer, and hereby undertakes to provide the SEC staff or a security holder of the Issuer, upon request, information regarding the number of shares sold at each respective price within the range set forth in this footnote. Stock option granted to the reporting person on May 6, 2013 vested in eight (8) equal quarterly installments and was fully-vested as of May 6, 2015. /s/ Mark R. Ziebell 2023-05-02